We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$3M
Cap. Flow %
0.15%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Top Buys

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$8.42M
2
MPC icon
Marathon Petroleum
MPC
+$5.47M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$5.39M
4
ORLY icon
O'Reilly Automotive
ORLY
+$5.32M
5
CROX icon
Crocs
CROX
+$5.07M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.6M
2
TPR icon
Tapestry
TPR
+$12M
3
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$8.32M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.96M
5
SAGE
Sage Therapeutics
SAGE
+$6.93M

Sector Composition

Rank Sector Weight
1 Miscellaneous 85.48%
2 Healthcare 3.75%
3 Consumer Discretionary 2.73%
4 Technology 1.96%
5 Energy 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPD icon
551
Enterprise Products Partners
EPD
$82.3B
$234K 0.01%
8,100
– –
CCXI
552
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
$233K 0.01%
+25,000
New +$289K
ATNX
553
DELISTED
Athenex, Inc. Common Stock
ATNX
$229K 0.01%
+580
New +$161K
AMRS
554
CALL
DELISTED
Amyris Inc.
AMRS
$228K 0.01%
+64,000
New +$252K
BMY icon
555
Bristol-Myers Squibb
BMY
$130B
$227K 0.01%
5,000
-270,000
-98% -$12.6M
KIN
556
DELISTED
Kindred Biosciences, Inc.
KIN
$225K 0.01%
+27,000
New +$233K
SIRI icon
557
SiriusXM
SIRI
$9.63B
$224K 0.01%
4,000
-10,121
-72% -$576K
KRA
558
DELISTED
Kraton Corporation
KRA
$221K 0.01%
+7,100
New +$215K
GPOR
559
CALL
DELISTED
Gulfport Energy Corp.
GPOR
$221K 0.01%
45,000
– –
MNTA
560
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$218K 0.01%
+17,500
New +$232K
MNTA
561
PUT
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$218K 0.01%
+17,500
New +$232K
MDR
562
PUT
DELISTED
McDermott International
MDR
$217K 0.01%
22,500
-90,000
-80% -$719K
INDP icon
563
PUT
Indaptus Therapeutics
INDP
$428M
$216K 0.01%
+22
New +$277K
DSKE
564
DELISTED
Daseke, Inc. Common Stock
DSKE
$216K 0.01%
+60,000
New +$284K
CBAY
565
DELISTED
Cymabay Therapeutics
CBAY
$215K 0.01%
+30,000
New +$340K
DPLO
566
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$213K 0.01%
+35,000
New +$186K
DERM
567
DELISTED
Dermira, Inc.
DERM
$210K 0.01%
+22,000
New +$237K
MFIN icon
568
CALL
Medallion Financial
MFIN
$272M
$202K 0.01%
+30,000
New +$206K
CHS
569
DELISTED
Chicos FAS, Inc.
CHS
$202K 0.01%
+60,000
New +$218K
CHS
570
PUT
DELISTED
Chicos FAS, Inc.
CHS
$202K 0.01%
+60,000
New +$218K
IMGN
571
CALL
DELISTED
Immunogen Inc
IMGN
$195K 0.01%
90,000
-135,000
-60% -$319K
SGMO
572
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$189K 0.01%
+17,500
New +$186K
MRNS
573
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$187K 0.01%
+11,250
New +$195K
YPF icon
574
YPF Sociedad Anonima ADS
YPF
$21.4B
$182K 0.01%
10,000
-20,000
-67% -$308K
KPTI icon
575
Karyopharm Therapeutics
KPTI
$38.6M
$180K 0.01%
+2,000
New +$161K
21 22
23
24 25

Similar funds

AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $21.4B AUM
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management's Q2 2019 filing shows 395 new, 92 increased, 99 reduced and 294 closed positions. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M. The largest sale was Bristol-Myers Squibb, an estimated $12.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 85% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.